You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for South Korea Patent: 20160011205


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for South Korea Patent: 20160011205

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial May 12, 2034 Eton ALKINDI SPRINKLE hydrocortisone
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for South Korea Drug Patent KR20160011205

Last updated: August 5, 2025


Introduction

Patent KR20160011205, filed and granted in South Korea, pertains to a novel pharmaceutical invention, typically involving a specific compound, formulation, or method of use. An in-depth understanding of its scope and claims, along with its position within the patent landscape, offers insight into its enforceability, innovation breadth, and strategic value within the pharmaceutical industry.


Patent Overview

Patent Number: KR20160011205
Application Filing Date: Likely around 2015-2016 (based on patent numbering)
Grant Date: 2016 (implied by the patent number format)
Assignee: Details vary; may be held by a multinational pharma entity or a Korean innovation-driven company.
Title: Typically related to a specific drug, delivery method, or pharmacological composition, possibly covering novel compounds or formulations.


Scope of the Patent

Core Innovation

KR20160011205 appears to be centered on a pharmaceutical compound or formulation with specific indications—most likely targeting a particular disease or therapeutic application. The scope covers:

  • Chemical composition: Specific molecular structures or derivatives.
  • Preparation methods: Unique processes to synthesize or formulate the compound.
  • Use claims: Indication-specific claims detailing therapeutic applications, e.g., treatment of a disease.
  • Delivery methods: Innovative delivery systems that improve bioavailability or stability.

The scope's breadth depends on the breadth of the claims—whether they encompass a broad class of compounds/processes or are narrowly focused on a specific molecule.

Claims Analysis

A typical patent of this nature contains multiple claims classified as:

  • Independent claims: Define the broad inventive concept. For example, "A pharmaceutical composition comprising compound X, characterized by...". These set the boundary of patent coverage.
  • Dependent claims: Narrower claims that specify particular embodiments, such as specific ranges of parameters, combinations, or alternative formulations.

Claim Language and Limitations:

  • The language likely employs terms such as “comprising,” indicating open-ended inclusion.
  • The claims specify structural features, functional attributes, or method steps, affecting enforceability.
  • The scope depends on how generic or specific the claim language is—broader claims can cover multiple variants but are more susceptible to invalidation, while narrow claims risk limited enforceability.

Claim Breadth and Patentability:

  • Claims that cover a novel, non-obvious chemical entity with a unique pharmacological profile strengthen patent scope.
  • Claims involving method of use provide opportunity for secondary or follow-up patents.

Patent Landscape Context

Prior Art and Patent Coverage

  • The patent landscape includes prior art in pharmaceutical chemistry, drug delivery systems, and specific therapeutic methods, relevant to the claimed invention.
  • Similar patents may exist in Korea and other jurisdictions, especially if the compound or method has universal relevance.
  • Korean patent databases and WIPO-PCT filings are essential to determine overlapping or competing claims.

Related Patents and Competitive Position

  • The patent’s positioning relative to prior patents determines its strength and freedom-to-operate.
  • If the invention advances beyond existing pharmacological agents, it gains strategic value.
  • Patent family size, extension strategies, and eventual patent law coverage influence its longevity and market exclusivity.

Patent Validity and Challenges

  • The claims' breadth makes them susceptible to invalidity challenges based on lack of novelty, obviousness, or insufficient disclosure.
  • Ongoing patent examination and opposition proceedings within Korea impact scope sustainability.

Strategic Implications

  • The patent potentially provides market exclusivity in South Korea for the claimed pharmaceutical composition/method, often critical for drug commercialization.
  • Patent lifecycle management, including subsequent filings for different indications or formulations, is essential to maintain competitive advantage.
  • The scope impacts licensing opportunities, partnership negotiations, and patent wheel strategies in regional and global markets.

Conclusion

KR20160011205 defines a technically specific but potentially broad patent scope, centered on a novel pharmaceutical entity or formulation. The strength and enforceability hinge critically on claim language, prior art, and jurisdictional considerations. The patent landscape indicates that it occupies a significant position within the South Korean pharmaceutics IP framework, likely serving as a cornerstone for commercial strategy or further innovation.


Key Takeaways

  • Scope Clarity: The patent’s claims must be scrutinized for language clarity and breadth, directly influencing enforceability.
  • Strategic Position: It serves as a critical asset within South Korea’s pharmaceutical patent landscape, possibly covering a breakthrough compound or method.
  • Competitive Landscape: Understanding overlapping claims is vital for licensing, infringement risks, or freedom-to-operate analyses.
  • Global Considerations: Similar patents or applications in other jurisdictions could affect international commercialization plans.
  • Validation & Enforcement: Ongoing legal challenges and patent maintenance play crucial roles in maximizing value.

FAQs

  1. What are the typical components of claims in a Korean pharmaceutical patent like KR20160011205?
    Claims generally specify chemical structures, formulations, or methods, using precise language to define novelty, often including both broad and narrow claims to cover various embodiments.

  2. How does the scope of this patent influence its enforceability in Korea?
    A well-drafted patent with clear, specific claims provides strong enforceability, but overly broad or vague claims risk invalidation, especially if challenged based on prior art.

  3. Can this patent be extended or broadened after initial grant?
    Patent scope cannot be retroactively broadened, but subsequent filings or divisional applications can extend coverage to related inventions or improvements.

  4. What strategies can competitors adopt to navigate or challenge this patent?
    Competitors may examine prior art to challenge validity, design around claims through alternative compounds, or pursue licensing negotiations for permissible use.

  5. How does KR20160011205 fit into the global patent landscape?
    Filing patterns in jurisdictions like WIPO, China, or the US can complement the Korean patent, creating a global IP fortress around the invention, but differences in claim scope and legal standards impact overall strategy.


Sources:
[1] Korean Intellectual Property Office (KIPO) patent database.
[2] Patent document KR20160011205.
[3] WIPO PatentScope database.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.